Schizophrenia News and Research

Latest Schizophrenia News and Research

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Survey on treatment for schizophrenia sheds new light on what people with schizophrenia feel is important for long-term quality care

Details from a large-scale survey focusing on treatment goals for schizophrenia shed new light on what physicians and people with schizophrenia feel is important for long-term quality care, according to Ronald J. Diamond, M.D., co-author of the study.

13 Oct 2004

Innovative help for parents of autistic children

In 1997, the Pennsylvania Department of Education held a focus group of parents with autistic children throughout the state to learn more about their needs. George Shadie of Luzerne County was one of those parents.

11 Oct 2004

Stem cells and drug design

Victorian College of Pharmacy researchers hope stem cells will help them better understand the action of existing drugs and aid in the discovery of new drugs for illnesses such as depression, obesity and anxiety.

5 Oct 2004

Personality disorder symptoms can change with time

Personality disorder symptoms are supposed to be stable, enduring, and persistent across the lifespan, however researchers at Binghamton University, State University of New York, and Harvard report evidence that such disabling psychiatric conditions are flexible and appreciable change over time is possible.

4 Oct 2004

People with mental disorders develop cancer at younger ages

People with mental disorders develop cancer at younger ages and have higher odds of later being diagnosed with certain cancers, including tumors of the brain and lung, according to a new analysis of insurance claims.

4 Oct 2004

Findings have implications for understanding psychiatric and neurological disease that affect the hippocampus

Spatial memory is more vulnerable than object recognition memory when damage occurs in the brain’s memory processing center, the hippocampus, according to memory specialists at the University of California, San Diego (UCSD) School of Medicine

27 Sep 2004

NIH opens new hospital totally dedicated to clinical research

This new hospital totally dedicated to clinical research — research involving patients — is the most significant addition to the NIH campus in more than 50 years and provides a unique opportunity for scientists, clinicians, and patients to study and conquer both chronic and acute disease in the 21st century.

22 Sep 2004

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

An intriguing link between a mother’s stress levels during pregnancy and the effect on the brain of her unborn baby is revealed in a new study of children born in Bristol, England.

20 Sep 2004

Study highlights relationship between schizophrenia and suicide in China

The potential relationship of two important public health problems for China—schizophrenia and suicide—is highlighted by an epidemiological study in this week’s issue of THE LANCET.

17 Sep 2004

New genetic hypothesis for the cause of autism

Researchers have proposed a new hypothesis on the cause of autism, suggesting a mixed epigenetic and genetic and mixed de novo and inherited (MEGDI) model.

8 Sep 2004

Research suggests that victimisation in childhood increases risk of psychotic disorders, such as schizophrenia or manic depression

People with psychosis report a marked excess of victimising experiences, many of which occurred during childhood, according to a new study.

2 Sep 2004

Knowing more about a gene’s responsibility will stir up a swarm of controversy

Pinning down how genetics contributes to behavior is slippery business. For instance, identifying the genes linked to a likelihood of developing schizophrenia or autism could stigmatize those who possess the genes, and may even play a role in defining the conditions themselves.

1 Sep 2004

Further evidence of a genetic link to schizophrenia

Mice with specific genetic mutations exhibit behavior similar to human psychosis, report UT Southwestern Medical Center at Dallas researchers, providing further support to the notion of a genetic link to schizophrenia.

30 Aug 2004

Link between marijuana and mental health

An eminent University of Melbourne Psychiatry Professor will lead a conference detailing the latest research findings on the link between marijuana and mental health.

16 Aug 2004

Relationship between brain chemical messenger glutamate and schizophrenia traits

Researchers at the NIH's National Institute of Mental Health (NIMH) have identified a relationship between a small section of one gene, the brain chemical messenger glutamate, and a collection of traits known to be associated with schizophrenia.

15 Aug 2004

Gene responsible for management of glutamate is a promising candidate in determining risk for schizophrenia

Researchers at the National Institute of Mental Health have identified a relationship between a small section of one gene, the brain chemical messenger glutamate, and a collection of traits known to be associated with schizophrenia.

11 Aug 2004

Scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning

Using a new molecular genetic technique, scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning. Without the gene, the monkeys lost their sense of balance between reward and the work required to get it, say researchers at the National Institute of Mental Health .

11 Aug 2004

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system that cause Australians incalculable distress as well as costing billions of dollars each year in treatment and care.

9 Aug 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

Schizophrenia News and Research

Latest Schizophrenia News and Research

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Survey on treatment for schizophrenia sheds new light on what people with schizophrenia feel is important for long-term quality care

Innovative help for parents of autistic children

Stem cells and drug design

Personality disorder symptoms can change with time

People with mental disorders develop cancer at younger ages

Findings have implications for understanding psychiatric and neurological disease that affect the hippocampus

NIH opens new hospital totally dedicated to clinical research

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

Study highlights relationship between schizophrenia and suicide in China

New genetic hypothesis for the cause of autism

Research suggests that victimisation in childhood increases risk of psychotic disorders, such as schizophrenia or manic depression

Knowing more about a gene’s responsibility will stir up a swarm of controversy

Further evidence of a genetic link to schizophrenia

Link between marijuana and mental health

Relationship between brain chemical messenger glutamate and schizophrenia traits

Gene responsible for management of glutamate is a promising candidate in determining risk for schizophrenia

Scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning

Neuroscience research in South Australia is mobilising its efforts against diseases of the brain and nervous system

Approval of Cymbalta for treatment of major depressive disorder

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Schizophrenia News and Research

Latest Schizophrenia News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in